Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial

BACKGROUND: Despite major advances in transplant medicine, improvements in long-term kidney allograft survival have not been commensurate with those observed shortly after transplantation. The formation of donor-specific antibodies (DSA) and ongoing antibody-mediated rejection (AMR) processes may cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskandary, Farsad, Bond, Gregor, Schwaiger, Elisabeth, Kikic, Zeljko, Winzer, Christine, Wahrmann, Markus, Marinova, Lena, Haslacher, Helmuth, Regele, Heinz, Oberbauer, Rainer, Böhmig, Georg A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014747/
https://www.ncbi.nlm.nih.gov/pubmed/24708575
http://dx.doi.org/10.1186/1745-6215-15-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014747/
https://www.ncbi.nlm.nih.gov/pubmed/24708575
http://dx.doi.org/10.1186/1745-6215-15-107

Ejemplares similares